Cite
HARVARD Citation
Mauer, M. et al. (2017). Reduction of podocyte globotriaosylceramide content in adult male patients with Fabry disease with amenable GLA mutations following 6 months of migalastat treatment. Journal of medical genetics. 54 (11), pp. 781-786. [Online].